Global and Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis
  • 1.2.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate : 2020 VS 2026
  • 1.2.2 Immunological Test
  • 1.2.3 Pathogen Nucleic Acid Test
• 1.3 Market by Application
  • 1.3.1 Global Point of Care Testing for Infectious Disease Market Share 7: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2015-2026)
• 2.2 Global Point of Care Testing for Infectious Disease Growth Trends by Regions
  • 2.2.1 Point of Care Testing for Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Point of Care Testing for Infectious Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Point of Care Testing for Infectious Disease Players by Market Size
  • 3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2015-2020)
• 3.2 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
• 3.4 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
  • 3.4.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2019
• 3.5 Key Players Point of Care Testing for Infectious Disease Area Served
• 3.6 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
• 3.7 Date of Enter into Point of Care Testing for Infectious Disease Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care Testing for Infectious Disease Breakdown Data (2015-2026)

• 4.1 Global Point of Care Testing for Infectious Disease Historic Market Size (2015-2020)
• 4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size (2021-2026)

5 Point of Care Testing for Infectious Disease Breakdown Data 7 (2015-2026)

• 5.1 Global Point of Care Testing for Infectious Disease Historic Market Size 7 (2015-2020)
• 5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size 7 (2021-2026)

6 North America

• 6.1 North America Point of Care Testing for Infectious Disease Market Size (2015-2026)
• 6.2 North America Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 6.3 North America Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
• 6.4 North America Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Point of Care Testing for Infectious Disease Market Size (2015-2026)
• 7.2 Europe Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 7.3 Europe Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
• 7.4 Europe Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Point of Care Testing for Infectious Disease Market Size (2015-2026)
• 8.2 China Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 8.3 China Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
• 8.4 China Point of Care Testing for Infectious Disease Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Point of Care Testing for Infectious Disease Market Size (2015-2026)
• 9.2 Japan Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 9.3 Japan Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
• 9.4 Japan Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Point of Care Testing for Infectious Disease Market Size (2015-2026)
• 10.2 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Type (2015-2020)
• 10.3 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Application (2015-2020)
• 10.4 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Abbott Business Overview
  • 11.1.3 Abbott Point of Care Testing for Infectious Disease Introduction
  • 11.1.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2015-2020))
  • 11.1.5 Abbott Recent Development
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Roche Business Overview
  • 11.2.3 Roche Point of Care Testing for Infectious Disease Introduction
  • 11.2.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.2.5 Roche Recent Development
• 11.3 Siemens
  • 11.3.1 Siemens Company Details
  • 11.3.2 Siemens Business Overview
  • 11.3.3 Siemens Point of Care Testing for Infectious Disease Introduction
  • 11.3.4 Siemens Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.3.5 Siemens Recent Development
• 11.4 Danaher
  • 11.4.1 Danaher Company Details
  • 11.4.2 Danaher Business Overview
  • 11.4.3 Danaher Point of Care Testing for Infectious Disease Introduction
  • 11.4.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.4.5 Danaher Recent Development
• 11.5 Becton, Dickinson
  • 11.5.1 Becton, Dickinson Company Details
  • 11.5.2 Becton, Dickinson Business Overview
  • 11.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Introduction
  • 11.5.4 Becton, Dickinson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.5.5 Becton, Dickinson Recent Development
• 11.6 Johnson & Johnson
  • 11.6.1 Johnson & Johnson Company Details
  • 11.6.2 Johnson & Johnson Business Overview
  • 11.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Introduction
  • 11.6.4 Johnson & Johnson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.6.5 Johnson & Johnson Recent Development
• 11.7 Instrumentation Laboratory
  • 11.7.1 Instrumentation Laboratory Company Details
  • 11.7.2 Instrumentation Laboratory Business Overview
  • 11.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Introduction
  • 11.7.4 Instrumentation Laboratory Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.7.5 Instrumentation Laboratory Recent Development
• 11.8 PTS Diagnostics
  • 11.8.1 PTS Diagnostics Company Details
  • 11.8.2 PTS Diagnostics Business Overview
  • 11.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 11.8.4 PTS Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.8.5 PTS Diagnostics Recent Development
• 11.9 Quidel
  • 11.9.1 Quidel Company Details
  • 11.9.2 Quidel Business Overview
  • 11.9.3 Quidel Point of Care Testing for Infectious Disease Introduction
  • 11.9.4 Quidel Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.9.5 Quidel Recent Development
• 11.10 Sekisui Diagnostics
  • 11.10.1 Sekisui Diagnostics Company Details
  • 11.10.2 Sekisui Diagnostics Business Overview
  • 11.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 11.10.4 Sekisui Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 11.10.5 Sekisui Diagnostics Recent Development
• 11.11 Nova
  • 10.11.1 Nova Company Details
  • 10.11.2 Nova Business Overview
  • 10.11.3 Nova Point of Care Testing for Infectious Disease Introduction
  • 10.11.4 Nova Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.11.5 Nova Recent Development
• 11.12 EKF Diagnostics
  • 10.12.1 EKF Diagnostics Company Details
  • 10.12.2 EKF Diagnostics Business Overview
  • 10.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 10.12.4 EKF Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.12.5 EKF Diagnostics Recent Development
• 11.13 AccuBioTech
  • 10.13.1 AccuBioTech Company Details
  • 10.13.2 AccuBioTech Business Overview
  • 10.13.3 AccuBioTech Point of Care Testing for Infectious Disease Introduction
  • 10.13.4 AccuBioTech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.13.5 AccuBioTech Recent Development
• 11.14 Trinity Biotech
  • 10.14.1 Trinity Biotech Company Details
  • 10.14.2 Trinity Biotech Business Overview
  • 10.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Introduction
  • 10.14.4 Trinity Biotech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.14.5 Trinity Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer